My experience of cannabinoid hyperemesis syndrome CHS

Understanding Cannabinoid Hyperemesis Syndrome (CHS) is crucial as cannabis use continues to rise, especially among younger individuals. This complex condition, characterized by severe nausea, vomiting, and abdominal pain, often goes misdiagnosed due to its similarity to other gastrointestinal disorders. Recognizing CHS symptoms and seeking timely medical advice is vital, as early intervention can significantly enhance patient outcomes. If you have cannabinoid hyperemesis syndrome (CHS), the best treatment is to stop using weed, even if you’ve been doing it for years with no previous side effects. Once you do that, your repeated nausea and vomiting should go away and not return.

What is the treatment for cannabinoid hyperemesis treatment?

Although challenging, especially for those with cannabis addiction, abstaining is the only proven way to prevent symptom recurrence.Professional support is essential for those struggling to quit. Cannabis addiction treatment, counselling, and support groups can ease the process. For those needing more structure, cannabis rehab programs offer a safe and guided environment to help alcoholism symptoms them stop using cannabis. While hot showers can offer comfort, they’re only a temporary fix and don’t address the root cause. For lasting relief, individuals should consider reducing cannabis use and seeking medical support. Abstaining from cannabis remains the only known solution for overcoming CHS symptoms.

What Causes CHS?

Diagnosing CHS often involves recognizing the link between symptoms and heavy cannabis use. Risk factors include frequent use over many years, which can increase tolerance and prompt users to consume more, unknowingly risking adverse reactions. It’s a cannabis-related disorder that can emerge even after years of symptom-free use. Experts suggest that a buildup of cannabinoids in the body disrupts its natural balance, causing cannabis to trigger nausea instead of relief.

Immediate Effects:

In this phase, patients gradually resume normal eating and dietary habits. Patients experience complete relief of the symptoms, which can last days, chs syndrome weeks, or even months. The duration of this phase ranges from weeks to months, depending on resuming marijuana use, which may trigger another relapse.

We strongly advise consult with your physician before consuming any products displayed on this website. Relying on the information from this website is strictly at your discretion. You must take responsibility for abiding the law of the city, country or the jurisdiction where you are located. Many https://ecosoberhouse.com/ researchers tried to give more details on CHS and its causes, but it requires more studies as it is the newly described condition. The first cases were spotted in 2004 in South Australia, where doctors started treating cannabis users for vomiting, stomach pain, and more.

• Exogenous ligands, such as N-acyl ethanolamines and mono-acyl-glycerols, include notable compounds like THC (which contains a dibenzopyran ring), cannabidiol, cannabigerol, and cannabinol 23,30.
• Many CHS sufferers are reluctant to disclose their cannabis use, either out of fear of judgment or legal repercussions.
• Cannabis affects the body’s endocannabinoid system, which helps regulate various functions like mood, appetite, and pain.

The Rome IV criteria provide some objectivity to help with the diagnosis by placing CHS under the heading of functional gut-brain disorders, and consider it as a variant of CVS (Table 2). However, questions remain about the dosage of cannabis, individual and genetic susceptibility, abstinence period and the inclusion of abdominal pain as a criterion. The clinical effects of volume depletion dominate complications related to CHS.

Furthermore, this process requires considerable effort and motivation from the patient. The duration to achieve complete recovery from cannabis use disorder may range from a minimum of 3 months to up to 4 years 94. This variability in recovery time is partly attributable to its accumulation in adipose tissue and due to the extended half-life of THC. During this phase, patients may experience morning nausea, abdominal discomfort, or anxiety about vomiting.